APOE and atherosclerosis: In the current work, gene expression of key inflammatory and macrophage molecules is investigated in apoE−/− mice during the initiation and progression of early atherosclerosis, as well as in response to transgene expression of very low levels of apoE (<2 μg/ml) which are remarkably atheroprotective in apoE−/− mice [17].